Member Info for ShadowCelt

Sounds like the perfect way to suss out a company for a takeover IMO - Roche certainly have the wedge and more to buy us to get a strategic advantage and block other pharma from using

Had it not been for our scientists, we would not now be able to enjoy the most basic human freedoms. We are injecting funds to restore Britain’s status as a scientific superpower. https://www.telegraph.co.uk/politics/2021/06/20/injecting-funds-restore-britains-status-scientific-superpower/

Seems to be the Microsoft of Chemistry with that takeup - 50% of the world's Top 10 pharmaceutical organisations using DeepMatter products

Tuesdays RNS should be interesting

They have to be delivered by June 30th to Companies House for year ending 31st December 2020

It has been higher than 2.6 before but respect your decision, good luck in the markets

all the 2.06 are buys as well, definitely picking up again buy wise

900k shares at 2.07 is also a buy

My £2k (97563) top up also marked as a sell @2.05. Think MMs want to keep this down for some reason atm

Sorry mine was 2.125 not 2.15

MMs have stocked up by the looks as they aren't buying today, just grabbed another £3k @ 2.15

£10k buy is mine - lots of buys going through as red atm

Definitely an interesting time to be had here, but I’d be pleasantly surprised if SP doesn’t drift to placing price first. 9 times out of 10 it follows that path. A few buck the trend

Level 2 is stacked 3 to 1 - MMs happy to take as many shares as they can, wouldn't be surprised to see bigger delayed buys come through soon and back up it will go

On 29 January 2021 shares fell around 11% whe disappointment the company didn’t announce an extension to its contract with the Department for Health and Social Care. As well as securing two contracts with the DHSC, Novacyt is supplying Covid-19 products to non-government organisations and has expanded its global presence. Aside from the UK, the firm’s biggest markets are the Middle East, Germany and the US.

At the time Novacyt said demand for its products remained strong so far in 2021 and was expected to remain so throughout the rest of the year with the conversion of new opportunities including several new product launches.

On Wednesday 24th February shares gained 6% to 725p following an update on its research and development (R&D) activities and strong new product pipelines.

Fridays news was therefore partly priced in from the January announcement and certainly (in my opinion) did not warrant such a substantial drop when some many other contracts / markets / opportunities exist.

Expecting a decent bounce and then we can get back to business and the exciting times ahead.

15 minutes in and zero trades.....

Microsoft in Talks to Buy Discord for More Than $10 Billion - and thats how easy tech firms can get taken out

Id be more surprised if its not days / a few weeks at most - agree advanced discussions implies that

https://www.argusmedia.com/en/news/2171630-india-loses-cairn-energy-arbitration-case

Yes it is up 20% you are correct but still think this is getting increased traction in markets